{"id":"W4376225548","doi":"10.1007/s00277-023-05196-4","title":"RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma","year":2023,"lang":"en","type":"article","venue":"Annals of Hematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; University of Alberta","funders":"National Cancer Institute; MorphoSys","keywords":"Lenalidomide; Medicine; Rituximab; Internal medicine; Bendamustine; Oncology; Clinical endpoint; Surgery; Multiple myeloma; Lymphoma; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001559717,0.0006175572,0.002611426,0.001354357,0.0001258622,0.00002343567,0.0006303233,0.0002788845,0.0001121814],"category_scores_gemma":[0.0004413593,0.0005250223,0.000181027,0.001461029,0.0007474063,0.0002441852,0.0003832945,0.0005980902,0.00002726405],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001915257,"about_ca_system_score_gemma":0.0007240077,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001544861,"about_ca_topic_score_gemma":0.001754915,"domain_scores_codex":[0.9945056,0.001267601,0.001024225,0.001141476,0.001027925,0.001033204],"domain_scores_gemma":[0.9922414,0.004494512,0.0006358808,0.001872471,0.0004776463,0.0002780609],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5369094,0.04756203,0.3766467,0.006482841,0.002607852,0.001190092,0.005021133,0.0001096653,0.01468014,0.001786281,0.003669022,0.003334859],"study_design_scores_gemma":[0.5114033,0.01253718,0.380853,0.002858996,0.0003968383,0.00002525905,0.002904654,0.004699406,0.08098858,0.0001328635,0.001988528,0.001211421],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9947041,0.0008646905,0.00001774861,0.0004840807,0.0001814985,0.001626892,0.0005656123,0.00008459067,0.001470831],"genre_scores_gemma":[0.9978828,0.0003256918,0.0001459467,0.0001583385,0.00004365796,0.00007358437,0.001136909,0.0001096671,0.0001234473],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06630843,"threshold_uncertainty_score":0.9997202,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0815092479124416,"score_gpt":0.3680034390507228,"score_spread":0.2864941911382812,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}